A

Acumen Pharmaceuticals
D

ABOS

3.16000
USD
-0.03
(-0.78%)
مغلق
حجم التداول
30,806
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
228,522,621
المقالات
المزيد

العنوان: Acumen Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.